These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 5605712)

  • 101. Results of the use of a new beta-adrenergic blocker (LB 46) in angina pectoris.
    Aravanis C; Michaelides G
    Acta Cardiol; 1970; 25(5):501-9. PubMed ID: 4395273
    [No Abstract]   [Full Text] [Related]  

  • 102. [Atrial electrostimulation as a diagnostic and function test in examination of patients with angina pectoris].
    Gavrilescu S; Streian C; Pop T; Cotoi S
    Med Interna (Bucur); 1971 Aug; 23(8):937-46. PubMed ID: 4398441
    [No Abstract]   [Full Text] [Related]  

  • 103. [Beta-blocking agents in the treatment of angina pectoris].
    Lund-Larsen PG
    Tidsskr Nor Laegeforen; 1972 Feb; 92(5):355-7. PubMed ID: 4401368
    [No Abstract]   [Full Text] [Related]  

  • 104. [Changes in systemic blood viscosity during the exercise test in angina pectoris].
    Forconi S; Guerrini M; Rossi C; Pecchi S; Di Perri T
    Boll Soc Ital Cardiol; 1977; 22(4):435-40. PubMed ID: 617289
    [No Abstract]   [Full Text] [Related]  

  • 105. [What is certain in the therapy of coronary insufficiency?].
    Michel D
    Fortschr Med; 1972 Sep; 90(25):889-92. PubMed ID: 4404925
    [No Abstract]   [Full Text] [Related]  

  • 106. [Clinical value of beta-adrenergic receptor blocking agents].
    Chmielewski T
    Wiad Lek; 1970 Aug; 23(15):1317-20. PubMed ID: 4917574
    [No Abstract]   [Full Text] [Related]  

  • 107. [Cardiac function during exercise in effort angina. Part 1. A comparative study of dynamic exercise and static exercise (author's transl)].
    Itoh K
    Nihon Naika Gakkai Zasshi; 1981 Oct; 70(10):1388-400. PubMed ID: 7328358
    [No Abstract]   [Full Text] [Related]  

  • 108. [Adaptation of the circulatory system to physical exertion in patients with coronary disease and in healthy persons after administration of beta-methyldigoxin].
    Ziółkowski L; Wójcik-Ziółkowska E
    Pol Tyg Lek; 1986 Jan; 41(4):103-6. PubMed ID: 3703731
    [No Abstract]   [Full Text] [Related]  

  • 109. [Use of LB-46 in angina pectoris and cardiac arrhythmias].
    Maranhão MF; da Cunha GP; Rojas RI
    Arq Bras Cardiol; 1972 Feb; 25(1):51-60. PubMed ID: 4403346
    [No Abstract]   [Full Text] [Related]  

  • 110. [Recent acquisitions on beta blocking agents].
    Lesbre JP; Mériel P; Baledent M
    Therapeutique; 1971 Nov; 47(9):797-9. PubMed ID: 4401847
    [No Abstract]   [Full Text] [Related]  

  • 111. [Treatment of patients with ischemic heart diseases using senzit].
    Zamotaev IP; Venediktova MG; Zakharova GIu
    Klin Med (Mosk); 1988 Aug; 66(8):68-71. PubMed ID: 3193737
    [No Abstract]   [Full Text] [Related]  

  • 112. [A new beta-blockader, LB-46 (Visken): electrocardiographic control of its therapeutic action in angina patients].
    Saner R
    Therapie; 1970; 25(2):393-501. PubMed ID: 4403159
    [No Abstract]   [Full Text] [Related]  

  • 113. [Effect of passive smoking on the physical tolerance of ischemic heart disease patients].
    Khalfen ESh; Klochkov VA
    Ter Arkh; 1987; 59(5):112-5. PubMed ID: 3616927
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Oxoprenolol in angina pectoris.
    Lewis BS; Bakst A; Gotsman MS
    S Afr Med J; 1972 Aug; 46(34):1209-14. PubMed ID: 5056770
    [No Abstract]   [Full Text] [Related]  

  • 115. [The effect of molecular-iodine baths on the central hemodynamics of patients with hypertension and ischemic heart disease].
    Vinogradova MN; Mandrykina TA; Lavrov GK; Shchegoleva EA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1990; (4):15-8. PubMed ID: 2275098
    [No Abstract]   [Full Text] [Related]  

  • 116. [Letter: Oral strophanthin therapy in old age].
    Adolphs B
    MMW Munch Med Wochenschr; 1975 Mar; 117(10):412-3. PubMed ID: 804607
    [No Abstract]   [Full Text] [Related]  

  • 117. [The importance of Lopion (molsidomine) in the therapy of myocardial ischemia and angina pectoris].
    Trifunović S; Pavlović K
    Med Pregl; 1987; 40(1-2):17-21. PubMed ID: 3657717
    [No Abstract]   [Full Text] [Related]  

  • 118. Effects of ouabain on the left ventricular response to exercise in patients with angina pectoris.
    Glancy DL; Higgs LM; O'Brien KP; Epstein SE
    Circulation; 1971 Jan; 43(1):45-57. PubMed ID: 5540851
    [No Abstract]   [Full Text] [Related]  

  • 119. [Beta blocking therapy in cardiac rhythm disorders and angina pectoris].
    Di Matteo J; Vacheron A; Heulin A
    Therapeutique; 1972 Feb; 48(2):101-4. PubMed ID: 4403141
    [No Abstract]   [Full Text] [Related]  

  • 120. [Clinical trials with the beta adrenergic blocking agent Visken].
    Holló J; Szám I
    Orv Hetil; 1972 Jun; 113(26):1530-3. PubMed ID: 5038972
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.